Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jan;3(1):14-7.
doi: 10.4103/0973-6247.45256.

Clinical significance of antibody to hepatitis B core antigen in multitransfused hemodialysis patients

Doaa M Elghannam, Rabab M Aly, Enas F Goda, Ehab E Eltoraby, Raghda E Farag

Clinical significance of antibody to hepatitis B core antigen in multitransfused hemodialysis patients

Doaa M Elghannam et al. Asian J Transfus Sci. 2009 Jan.

Abstract

Background: In spite of the progress made in the prevention of transfusion transmitted infections over the last few years, transmission of HBV infection through transfusion of HBsAg negative blood has been documented.

Objectives: To assess the frequency and clinical significance of anti-HBc in multitransfused hemodialysis patients.

Materials and methods: One hundred and forty-three hemodialysis patients who had been receiving blood regularly with an average of 39.4 +/- 7.579 months on hemodialysis were enrolled in this study. HBV markers (HBsAg, anti-HBc, anti-HBs) were measured in these patients and in 100 healthy controls by the ELISA technique. The following data were obtained for all patients: socio demographic data, number of blood transfusions and some laboratory investigations.

Results: In our patients, anti-HBc was positive in 9%, anti HBs in 7%, coexistant HbsAg/anti-HBc in 2.8% and anti HBc/anti HBs in 18.9%, meanwhile no patients were positive for HBsAg alone. In patients with only positive anti-HBc, the levels of anti-HBc were significantly related to abnormal results of liver function. In patients with positive anti-HBs/anti-HBc (n = 27), 18 patients had abnormal liver function, and 9 patients had normal liver function with no significant difference between them.

Conclusions: This study suggests that hepatitis B prevalence in our multitransfused hemodialysis patients is far in excess of that anticipated on the basis of HBsAg prevalence. Absence of HBsAg in the blood of hemodialyzed patients may not be sufficient to ensure lack of circulating HBV, and isolated positivity of anti-HBc may be a possible indicator of active hepatitis B infection.

Keywords: Anti-HBc; hemodialysis patients; hepatitis B infection.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Similar articles

See all similar articles

Cited by

References

    1. Shaaban FA, Hassanin AI, Samy SM, Salama SI, Said ZN. Said Longterm immunity to hepatitis B among a sample of fully vaccinated children in Cairo, Egypt. East Mediterr Health J. 2007;13:750–7. - PubMed
    1. Crovari P. Epidemiology of hepatitis B virus infection in Italy. Viral Hepatitis. 2003;11:7–8.
    1. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Ann Rev Immunol. 1995;13:29–60. - PubMed
    1. Alvarez-Munoz T, Bustamante-Calvillo E, Martinez-Garcia C, Morena-Altamirano L, Guiscafre-Gallardo H, Guiscafre JP, et al. Seroepidemiology of the hepatitis B and delta in the southeast of Chiapas, Mexico. Arch Investig Med. 1989;20:189–95. - PubMed
    1. Balderas-Renteria LE, Munoz-Espinosa MA, Dector-Carrillo FJ, Martinez-Martinez HA, Barrera-Saldaña HA. Detection of hepatitis B virus in seropositive and seronegative patients with chronic liver disease using DNA amplification by PCR. Arch Med Res. 2002;33:566–71. - PubMed